Ann: ADVENT-AML Phase 1B clinical trial update, page-93

First 93 Last

Share
Profile

Follow
johndprent

4,395 Posts.

4555

18/05/25

18:21

Post #: 79091161
Share

Originally posted by abitlikeme: ↑

Of course you are, your original comment clearly stated that the announcement was likely published
“with the sole intention of raising more cash and with no way of identifying if these responses were any way attributable to NK Cells.”
That strongly implies the data is being used in a misleading way — which, whether intentional or not, casts doubt on the integrity of the parties involved.

So yes, by questioning the credibility of the results and suggesting they were released purely to raise funds — despite being generated by MD Anderson and led by Dr Maiti, a respected haematologist — you are indirectly implying that they’ve allowed their names and reputations to be used in a way that lacks scientific integrity. That’s not a light accusation, even if it's couched in speculation.

As for the timing — it’s actually not unusual for biotech companies to publish interim data from Phase 1B studies, especially when early signs of efficacy are observed in a difficult-to-treat population. These kinds of updates are both expected and appropriate, provided they’re transparent about the limited sample size and context — which this one was.

The fact that Dr Maiti didn’t issue a personal comment in the media release doesn’t mean there’s something “strange” going on. Investigators often communicate through trial data and institutional channels rather than individual commentary, especially in early-stage studies.

Let’s just be careful not to confuse healthy skepticism with misplaced doubt in a reputable clinical process and respected individuals.

Expand

You're conflating the issues.

Do I call into question COH's credibility? Absolutely not.

Am I suggesting what's unfolded is cause for concern regarding CHM's credibility? Absolutely.

Effectively a one liner about two patients partially responding to SOC treatment, while still receiving said treatment, and after spending longer in a trading pause than in a trading halt there's rumours of a CR floating around this site on the very same day...

ALARM BELLS.

CHM Price at posting: 0.8¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

ASX Market Close: Index treads water as Energy stocks surge | Monday June 16, 2025

NUZ

This stock is crafting a cure for Huntington's – and it's making progress

Monday's HotCopper trends: 4DS falls short, $30B bid for Santos | June 16, 2025

RC1

Redcastle teams up with Terra Mining to get revenue flowing at Redcastle Reef, Queen Alexandra projects

First 93 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.4¢		Change 0.000(0.00%)		Mkt cap ! $8.060M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.4¢	$432	98K

Buyers (Bids)

No.	Vol.	Price($)
26	22188206	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	25892021	31

View Market Depth

No.	Vol.	Price($)
26	22188206	0.004
42	25331939	0.003
16	14000507	0.002
10	59600000	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	25892021	31
0.006	13747410	16
0.007	4700000	4
0.008	8542434	6
0.009	3727673	6

Last trade - 13.15pm 16/06/2025 (20 minute delay)

CHM (ASX) Chart

Ann: ADVENT-AML Phase 1B clinical trial update, page-93

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

ASX Market Close: Index treads water as Energy stocks surge | Monday June 16, 2025

This stock is crafting a cure for Huntington's – and it's making progress

Monday's HotCopper trends: 4DS falls short, $30B bid for Santos | June 16, 2025

Redcastle teams up with Terra Mining to get revenue flowing at Redcastle Reef, Queen Alexandra projects

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: ADVENT-AML Phase 1B clinical trial update, page-93

Top Stories

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

ASX Market Close: Index treads water as Energy stocks surge | Monday June 16, 2025

This stock is crafting a cure for Huntington's – and it's making progress

Monday's HotCopper trends: 4DS falls short, $30B bid for Santos | June 16, 2025

Redcastle teams up with Terra Mining to get revenue flowing at Redcastle Reef, Queen Alexandra projects

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News